Will Cannabis Seeds Be Restricted?

A redefinition of hemp under federal law, scheduled to take effect Nov. 12, spells the loss of Farm Bill safeguards for numerous hemp-derived THC items across the nation: mild beverages as well as THCA flower and delta-8 THC edibles, vapes and other products available at gas stations and smoke shops.

But the hemp prohibition also creates a major complication for the legal cannabis industry. Seeds from cannabis varieties that generate flower with more than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will probably continue in authorized states, the modifications threaten to close some seed banks and genetics companies, observers note, while creating supply-chain issues for cannabis growers and retailers.

“If this language goes forward, we will require pop-up stores to sell seeds in each state where it’s permitted,” Campanella said. “Which is why we’re also providing clones and tissue cultivation, because that’s not included in the bill.”

When are cannabis genetics and clones illegal to ship across state lines?

The updated regulations classify seeds depending on the THC capacity of the parent plant. Genetic material such as seeds and clones are rendered illegal if the final product exceeds the threshold.

For now, seeds are still shipping under the 2018 Farm Bill’s current quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis growers who worry about supply chain interruptions if out-of-state availability to genetics is banned.

Most of the cannabis sector remains mostly unaware of the approaching shutdown of the interstate genetics marketplace, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without federal intervention in the way of an exception for seeds or a general moratorium, numerous seed suppliers will just be shuttered by November, he added.

“We are operating legally currently, but if that shifts, it will disrupt the legal licensed industry in every state,” said Power, whose customers includes seed suppliers as well as licensed commercial cultivators.

“Consumers are going to forfeit choice, and it will be a major shutdown for most people.”

What are cannabis seed banks doing to remain legal after the government hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also limiting hemp-derived THC products to licensed cannabis retailers.

Formerly a seed supplier, Silberhaze is currently focused on the branding, preservation and IP protection of premium plant genetics.

That’s because seed companies hoping to remain compliant in this new environment must have airtight documentation, he said.

“You have to prove where this material comes from, so it’s extremely important to have records, even to the extent where you have cultivator names,” Silber said.

“Small businesses will have to operate with improved records and a better chain of custody,” he added. “We want that documentation too, because we don’t want to be dealing with shady sources.”

To avoid seizures and additional legal consequences, seed business owners must “get their affairs in order” before the updated regulations take place, Silber said.

“Review all your stuff immediately, and classify what you can,” Silber said. “Take stock, document your heritage, preserve cultivator records, and organize any cannabinoid or terpene data you currently have. If regulations change, you’ll be in a far better position to comprehend what may be impacted and make educated decisions.”

Does federal marijuana rescheduling affect cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be required for businesses engaged in research.

But for the time being, seed houses can’t register with the DEA like state-licensed medical cannabis operators can. Such a pathway is not available to seed suppliers, nurseries or genetics businesses, said Jim Ickes, a lawyer and nativesusa.com) partner with Frantz Ward’s cannabis law group in Cleveland.

“Genetics activity may be occurring inside larger state-licensed medical marijuana businesses, as some states allow dispensaries or registered medical operators to sell seeds, clones or home-cultivation materials,” he said.

“But that is distinct from the DEA creating a freestanding seed supplier registration category.”

Some genetics operators are already changing business practices to conform with the updated law. According to Ickes, they must address questions including:

  • Which of our lines produce plants above 0.3% total THC?
  • Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
  • What does our inventory look like once we organize it against the genetics exclusion?

Ickes also recognizes confusion from clients who believed federal rescheduling of medical marijuana would clarify their situation with banking institutions. However, the recent regulatory wording has shifted those conversations past the basics of classification, he said.

“Banks ask whether this specific revenue source is legal, whether it ties to state-licensed activity, or whether there’s cross-state risk,” said Ickes.

“After November, a seed bank selling drug-type genetics can’t address the initial question with the hemp classification. It has to point to a lawful state cannabis pathway instead. Seed banks dealing in authentic industrial-hemp seed keep the cleaner story.”

What’s the outlook of cannabis genetics?

Campanella is a member of a emerging coalition of other breeders, farmers and researchers that’s arguing seeds are more appropriately defined as agricultural inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement efforts elsewhere.

“How do you control something based on what it might become one day?” said Campanella. “Our preference is to have that language removed, or get seeds regulated by the USDA as a hemp product.”

But in the meantime, Campanella is reorganizing Brothers Grimm to operate outside the reach of changing federal oversight. The company plans to keep its Colorado seed facility while positioning its Oklahoma tissue culture facility as a hedge against federal prohibition of cannabis seeds.

As she explained: “If things evolve in a way where we can’t focus on interstate shipping, we’ll have additional resources to satisfy people’s requirements without putting ourselves in trouble.”